Lenvatinib is an oral tyrosine kinase inhibitor. It will in general be found accessible under the brand name Lenvima. Lenvatinib has been supported for use in isolated thyroid sickness, renal cell carcinoma, and hepatocellular carcinoma and actually for the treatment of endometrial dangerous development. https://hellos.blog/2024/10/how-much-does-epclusa-cost-hepatitis-c-treatment/